Here are three findings from the report:
• The general intravenous anesthesia drugs market is dominating the U.S. anesthesia drugs market.
• Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributors to intravenous anesthetic drugs.
• Baxter International, Endo Health Solutions, AstraZeneca and Abbott Laboratories are four main players, but other companies also play a major role in the market.
More articles on anesthesia:
NAPA Dr. Joseph Marino to study treatment for postoperative pain relief
ASA President Dr. J.P. Abenstein on the physician-led ASC anesthesia team
Dr. Eugene Pereira joins Sarasota Memorial Health Care System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.